THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 121 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $108,370 | -2.8% | 9,988 | +0.6% | 0.01% | 0.0% |
| Q4 2022 | $111,437 | -20.4% | 9,932 | -28.5% | 0.01% | -27.3% |
| Q3 2022 | $140,000 | +125.8% | 13,900 | +101.3% | 0.01% | +83.3% |
| Q2 2022 | $62,000 | -37.4% | 6,905 | +3.1% | 0.01% | -45.5% |
| Q3 2020 | $99,000 | -62.2% | 6,700 | -33.9% | 0.01% | -57.7% |
| Q4 2019 | $262,000 | +329.5% | 10,141 | +221.9% | 0.03% | +333.3% |
| Q3 2019 | $61,000 | -50.8% | 3,150 | -58.6% | 0.01% | -50.0% |
| Q2 2019 | $124,000 | +1277.8% | 7,600 | +1749.1% | 0.01% | +1100.0% |
| Q1 2018 | $9,000 | – | 411 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 10,747,108 | $299,737,000 | 20.21% |
| Foundation Asset Management, LP | 432,532 | $12,063,000 | 3.63% |
| Cormorant Asset Management, LP | 900,000 | $25,101,000 | 2.63% |
| Baupost Group | 9,309,168 | $259,633,000 | 2.57% |
| Old West Investment Management, LLC | 113,862 | $3,175,000 | 1.81% |
| Chescapmanager LLC | 293,017 | $8,172,000 | 1.33% |
| SENZAR ASSET MANAGEMENT, LLC | 171,800 | $4,792,000 | 1.22% |
| Virtus ETF Advisers LLC | 34,929 | $974,000 | 1.22% |
| Rock Springs Capital Management LP | 652,600 | $18,201,000 | 0.83% |
| FIRST MANHATTAN CO. LLC. | 1,454,167 | $40,556,000 | 0.22% |